BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35672474)

  • 1. Determining the efficacy of functional liver imaging score (FLIS) obtained from gadoxetic acid-enhanced MRI in patients with chronic liver disease and liver cirrhosis: the relationship between Albumin-Bilirubin (ALBI) grade and FLIS.
    Aslan S; Eryuruk U; Tasdemir MN; Cakir IM
    Abdom Radiol (NY); 2022 Jul; 47(7):2325-2334. PubMed ID: 35672474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the efficacy of the gadoxetic acid MRI-derived relative enhancement index (REI) and functional liver imaging score (FLIS) in predicting liver function: validation with Albumin-Bilirubin (ALBI) grade.
    Eryuruk U; Tasdemir MN; Karasu HI; Aslan S
    Abdom Radiol (NY); 2024 May; 49(5):1456-1466. PubMed ID: 38653813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of liver function in patients with liver cirrhosis and chronic liver disease using functional liver imaging scores at different acquisition time points.
    Tang G; Liu J; Liu P; Huang F; Shao X; Chen Y; Xie A
    Front Genet; 2022; 13():1071025. PubMed ID: 36561314
    [No Abstract]   [Full Text] [Related]  

  • 4. Validation of functional liver imaging scores (FLIS) derived from gadoxetic acid-enhanced MRI in patients with chronic liver disease and liver cirrhosis: the relationship between Child-Pugh score and FLIS.
    Lee HJ; Hong SB; Lee NK; Kim S; Seo HI; Kim DU; Han SY; Choo KS
    Eur Radiol; 2021 Nov; 31(11):8606-8614. PubMed ID: 33881570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inter- and intra-reader agreement for gadoxetic acid-enhanced MRI parameter readings in patients with chronic liver diseases.
    Beer L; Mandorfer M; Bastati N; Poetter-Lang S; Tamandl D; Stoyanova DP; Elmer MC; Semmler G; Simbrunner B; Hodge JC; Sirlin CB; Reiberger T; Ba-Ssalamah A
    Eur Radiol; 2019 Dec; 29(12):6600-6610. PubMed ID: 31001679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total Bilirubin Level as a Predictor of Suboptimal Image Quality of the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI in Patients with Extrahepatic Bile Duct Cancer.
    Hwang JA; Min JH; Kim SH; Choi SY; Lee JE; Moon JY
    Korean J Radiol; 2022 Apr; 23(4):389-401. PubMed ID: 35029076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gadoxetic acid-enhanced MRI-derived functional liver imaging score (FLIS) and spleen diameter predict outcomes in ACLD.
    Bastati N; Beer L; Ba-Ssalamah A; Poetter-Lang S; Ambros R; Kristic A; Lauber D; Pomej K; Binter T; Simbrunner B; Semmler G; Balcar L; Bican Y; Hodge JC; Wrba T; Trauner M; Reiberger T; Mandorfer M
    J Hepatol; 2022 Oct; 77(4):1005-1013. PubMed ID: 35525337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the Functional Liver Imaging Score Derived from Gadoxetic Acid-enhanced MRI Predict Outcomes in Chronic Liver Disease?
    Bastati N; Beer L; Mandorfer M; Poetter-Lang S; Tamandl D; Bican Y; Elmer MC; Einspieler H; Semmler G; Simbrunner B; Weber M; Hodge JC; Vernuccio F; Sirlin C; Reiberger T; Ba-Ssalamah A
    Radiology; 2020 Jan; 294(1):98-107. PubMed ID: 31743083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatobiliary phase images using gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced MRI as an imaging surrogate for the albumin-bilirubin grading system.
    Takatsu Y; Kobayashi S; Miyati T; Shiozaki T
    Eur J Radiol; 2016 Dec; 85(12):2206-2210. PubMed ID: 27842668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of Sufficient Liver Enhancement on the Gadoxetate Disodium-enhanced Hepatobiliary Phase Imaging Using Transitional Phase Images and Albumin-bilirubin Grade.
    Takatsu Y; Nakamura M; Kobayashi S; Miyati T
    Magn Reson Med Sci; 2021 Jun; 20(2):152-159. PubMed ID: 32461506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inter-reader reliability of functional liver imaging score derived from gadoxetic acid-enhanced MRI: a meta-analysis.
    Kim NH; Kang JH
    Abdom Radiol (NY); 2023 Mar; 48(3):886-894. PubMed ID: 36576517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of type 2 diabetes on liver images of GD-EOB-DTPA-enhanced MRI during the hepatobiliary phase.
    Zhang WY; Sun HY; Zhang WL; Feng R
    Sci Rep; 2023 Jan; 13(1):543. PubMed ID: 36631556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Orthotopic Liver Transplant Graft Survival on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Using Qualitative and Quantitative Parameters.
    Bastati N; Wibmer A; Tamandl D; Einspieler H; Hodge JC; Poetter-Lang S; Rockenschaub S; Berlakovich GA; Trauner M; Herold C; Ba-Ssalamah A
    Invest Radiol; 2016 Nov; 51(11):728-734. PubMed ID: 27175548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy of Mac-2-binding protein glycosylation isomer as a biomarker for albumin-bilirubin grade and the Controlling Nutritional Status score in chronic liver disease: investigation of cut-off values by the type of chronic liver disease.
    Ishikawa T; Kodama E; Kobayashi T; Azumi M; Nozawa Y; Iwanaga A; Sano T; Honma T
    Ann Palliat Med; 2022 Aug; 11(8):2658-2667. PubMed ID: 35815452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suboptimal hepatobiliary phase image in gadoxetic acid-enhanced liver MRI for the evaluation of the HCC: Predictive factors.
    Ryeom H; Chang Y; Park SY; Cho SH; Yeo B; Je H; Baek J
    Medicine (Baltimore); 2023 Nov; 102(46):e36176. PubMed ID: 37986292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A functional liver imaging score for preoperative prediction of liver failure after hepatocellular carcinoma resection.
    Luo N; Huang X; Ji Y; Jin G; Qin Y; Xiang B; Su D; Tang W
    Eur Radiol; 2022 Aug; 32(8):5623-5632. PubMed ID: 35294586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatobiliary phase images of gadoxetic acid-enhanced MRI may improve accuracy of predicting the size of hepatocellular carcinoma at pathology.
    Dong SY; Yang YT; Wang WT; Zhu S; Sun W; Zeng MS; Rao SX
    Acta Radiol; 2022 Jun; 63(6):734-742. PubMed ID: 33969700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined gadoxetic acid and gadofosveset enhanced liver MRI for detection and characterization of liver metastases.
    Bannas P; Bookwalter CA; Ziemlewicz T; Motosugi U; Munoz Del Rio A; Potretzke TA; Nagle SK; Reeder SB
    Eur Radiol; 2017 Jan; 27(1):32-40. PubMed ID: 27137648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Albumin-Bilirubin Score as a Predictor of Liver-Related Mortality in Primary Biliary Cholangitis with Compensated Cirrhosis.
    Chen Q; Zhong R; Wang Y; Kui Y; Wen X; Huang J; Jin Q
    Dig Dis; 2023; 41(6):946-956. PubMed ID: 37321186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
    Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI
    Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.